| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8778428 | European Urology | 2018 | 7 Pages |
Abstract
Patients with inherited DNA repair mutations benefit from standard therapies similarly to other metastatic prostate cancer patients.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Joaquin Mateo, Heather H. Cheng, Himisha Beltran, David Dolling, Wen Xu, Colin C. Pritchard, Helen Mossop, Pasquale Rescigno, Raquel Perez-Lopez, Verena Sailer, Michael Kolinsky, Ada Balasopoulou, Claudia Bertan, David M. Nanus, Scott T. Tagawa,